We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
Nasdaq:IBRX
​
​
logo

ImmunityBio (IBRX)

Nasdaq • IBRX • US45256X1037

8.29Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Options
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Nov 3, 2026, ORTEX estimates 30.3% of free float is sold short, 9.5 days to cover, cost to borrow 1%.

Market Cap

8.81b USD | # 1743 in US

Volume

11.41m shares | 96.58m USD

Shares Outstanding

1.06b

Free Float Shares

38.37% | 406.69m

DB:26CA|
XTRA:26CA

News

IBRX key data

ImmunityBio (Nasdaq: IBRX) has a market capitalization of $8.81B. Last close $8.29 (as of 2026-11-04); 52-week range $1.95 to $12.43. ORTEX data as of 2026-11-03: short interest is 30.29% of free float, 9.5 days to cover and the average cost to borrow is 1%.

  • IBRX news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.